Pharaoh Neuro, Inc.
PrivateLast Round
Series A
Feb 18, 2026
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pharaoh Neuro, Inc. operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a Series A round in February 2026.
Pharaoh Neuro, Inc. is a medical device company that develops innovative solutions for neurocritical care, including its Neurapheresis™ cerebrospinal fluid management system.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pharaoh Neuro, Inc. Comparables
Compare Pharaoh Neuro, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Minnetronix Medical | 85% | |
| BrainSpace | 84% | |
| EnClear Therapies | 78% |
For institutional investors. Book with your work email.
Pharaoh Neuro, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pharaoh Neuro, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arboretum Ventures | Series A |
| IAG Capital Partners | Series A |
| Hatteras Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 28, 2026
Grew 50% QoQ from 8 to 12 employees.
- May 15, 2026
Monthly visitors grew 57% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 29, 2026
Pharaoh Neuro, Inc. announces that the US Food and Drug Administration grants its Neurapheresis cerebrospinal fluid management system Breakthrough Device designation for accelerated removal of blood and blood-breakdown products from patients’ cerebrospinal fluid following aneurysmal subarachnoid haemorrhage on Oct 29th '26.
For institutional investors. Book with your work email.
Pharaoh Neuro, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pharaoh Neuro, Inc.'s valuation, stock price, and market status.
Is Pharaoh Neuro, Inc. a public or private company?
Pharaoh Neuro, Inc. is a private company.
What is the current stock price of Pharaoh Neuro, Inc.?
Pharaoh Neuro, Inc. is a private company, so its shares have no public market price. Caplight tracks Pharaoh Neuro, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pharaoh Neuro, Inc. worth (valuation)?
Valuation information for Pharaoh Neuro, Inc. is not publicly available.
Can I buy Pharaoh Neuro, Inc. stock?
Pharaoh Neuro, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pharaoh Neuro, Inc.'s last funding round?
Pharaoh Neuro, Inc.'s most recent funding round was Series A on February 18, 2026.
Who are the main investors in Pharaoh Neuro, Inc.?
Key investors in Pharaoh Neuro, Inc. include Arboretum Ventures.
Will Pharaoh Neuro, Inc. IPO soon?
No public IPO plans have been announced for Pharaoh Neuro, Inc..
How can I track Pharaoh Neuro, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pharaoh Neuro, Inc.'s shares on secondary markets.